BioHaven Pharmaceuticals announced the outcome from a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical trial of troriluzole as…
Just over a year ago, TrialSite introduced the exploits of the fake principal investigator named Sani Anwar, owner of Zain Research and Mid-Columbia Research, to…
A large health care workers union has recently made very serious allegations against a major U.S. health care company. Specifically, the National Nurses United (NNU),…
Levo Therapeutics announced top-line results from the Phase 3 CARE-PWS clinical study evaluating LV-101 (intranasal carbetocin) for the treatment of Prader-Willi Syndrome (PWS). CARE-PWS tested two doses of…
Lundbeck announced a decision to discontinue a phase II proof of concept clinical study of Lu AF11167 in patients with schizophrenia who are experiencing persistent negative symptoms. The…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
